38. スティーヴンス・ジョンソン症候群 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 19 / 薬物数 : 25 - (DrugBank : 10) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 98

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
0.05%cyclosporin EYE drop
   Mahidol University
      2007   Phase 4   NCT01488396   Thailand
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
   Imperial College London
      2012   Phase 4   EUCTR2012-003136-23-GB   United Kingdom
A single blood sample FOR HLA typing
   Sechenov University
      2017   -   NCT05284929   Russian Federation
Adalimumab injection
   Massachusetts Eye and Ear Infirmary
      2025   Phase 1   NCT06926478   United States
Allogeneic adipose tissue-derived mesenchymal stem cells expanded
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2022   Phase 2   EUCTR2021-005486-40-ES   Spain
Allogenic mesenchymal stem cell isolated from adipose tissue
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2022   Phase 2   EUCTR2021-005486-40-ES   Spain
Cultivated oral mucosal epithelial sheet transplantation
   Seoul National University Hospital
      2014   Phase 1/Phase 2   NCT02149732   Korea, Republic of
Double dose
   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2022   Phase 1/Phase 2   NCT05520086   Spain
Etanercept
   Abe Riichirou
      2021   Phase 2   JPRN-jRCTs031210325   -
Etanercept 50 MG SC DAY 1 and DAY 4
   Vanderbilt University Medical Center
      2023   Phase 3   NCT02987257   United States
Filgrastim
   Hospices Civils de Lyon - Direction de la Recherche Clinique
      2021   Phase 2;Phase 3   EUCTR2020-003544-83-FR   France
Harmonized supportive care
   Vanderbilt University Medical Center
      2023   Phase 3   NCT02987257   United States
HLA-B*5801 test
   Seoul National University Hospital
      2016   -   NCT03046914   Korea, Republic of
Infliximab
   Massachusetts Eye and Ear Infirmary
      2010   Phase 1/Phase 2   NCT01256489   United States
Intravenous immunoglobulin
   Nihon Pharmaceutical Co., Ltd
      2012   Phase 3   NCT01696500   Japan
Lamotrigine - generic product
   Imperial College London
      2012   Phase 4   EUCTR2012-003136-23-GB   United Kingdom
Methylprednisolone
   Morita Eishin
      2017   Phase 2   JPRN-jRCTs061180044   Germany;Japan;Taiwan
Palifermin
   Brett King
      2010   Phase 1/Phase 2   NCT02037347   United States
Prednisolone
   Morita Eishin
      2017   Phase 2   JPRN-jRCTs061180044   Germany;Japan;Taiwan
Riboflavin
   Joseph B. Ciolino, MD
      2012   Phase 1/Phase 2   NCT01582880   United States
Single dose
   Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2022   Phase 1/Phase 2   NCT05520086   Spain
Site specific standard OF care comparison
   Massachusetts General Hospital
      2024   -   NCT03585946   -
Tofacitinib
   Chang Gung Memorial Hospital
      2022   -   NCT06474078   Taiwan
Topical infliximab
   James Chodosh, MD, MPH
      2014   Phase 1/Phase 2   NCT02126020   Canada;United States
Zarzio
   Hospices Civils de Lyon - Direction de la Recherche Clinique
      2021   Phase 2;Phase 3   EUCTR2020-003544-83-FR   France